Literature DB >> 27309406

Sanguisorba officinalis L. Extracts Exert Antiobesity Effects in 3T3-L1 Adipocytes and C57BL/6J Mice Fed High-Fat Diets.

Da-Woon Jung1, Ok-Hwan Lee2, Il-Jun Kang1.   

Abstract

The purpose of this study was to investigate the antiobesity effect of Sanguisorba officinalis L. (SOL) in 3T3-L1 adipocytes and obese C57BL/6J mice. SOL was extracted with water and 30%, 50%, 70%, and 100% ethanol (EtOH). 3T3-L1 adipocytes were treated with SOL extracts (100 μg/mL) during the differentiation period. Triglyceride (TG) accumulation was determined by Oil Red O staining, and the expression of adipocyte-specific proteins was measured by Western blot analysis. C57BL/6J mice were fed a high-fat diet to induce obesity and were orally administered SOL 50% ethanol extract (50, 100, and 200 mg/kg) for 8 weeks. Among the SOL extracts, the 50% EtOH extract considerably inhibited TG accumulation through the downregulation of PPARγ, C/EBPα, and SREBP-1c in 3T3-L1 adipocytes. In addition, the 50% ethanol extract reduced body weight and adipose tissue weight and improved serum lipid profiles through downregulation of PPARγ, C/EBPα, FABP4, and ACC and upregulation of adiponectin and CPT-1 in obese C57BL/6J mice fed a high-fat diet. These results suggested that the SOL 50% EtOH extract may have an antiobesity effect through the regulation of transcription factors related to adipogenesis, lipogenesis, and lipolysis.

Entities:  

Keywords:  3T3-L1 adipocytes; Sanguisorba officinalis L.; adipogenesis; antiobesity; lipolysis

Mesh:

Substances:

Year:  2016        PMID: 27309406     DOI: 10.1089/jmf.2016.3704

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  2 in total

1.  Bioactivity-guided isolation and identification of anti-adipogenic compounds from Sanguisorba officinalis.

Authors:  Sun Hyuk Im; Zhiqiang Wang; Soon Sung Lim; Ok-Hwan Lee; Il-Jun Kang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

2.  Sanguisorbae Radix Suppresses Colorectal Tumor Growth Through PD-1/PD-L1 Blockade and Synergistic Effect With Pembrolizumab in a Humanized PD-L1-Expressing Colorectal Cancer Mouse Model.

Authors:  Eun-Ji Lee; Ji Hye Kim; Tae In Kim; Yeon-Ji Kim; Malk Eun Pak; Chang Hyun Jeon; Yeo Jin Park; Wei Li; Young Soo Kim; Jang-Gi Choi; Hwan-Suck Chung
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.